Paper · 65649

15/17 translocation, a consistent chromosomal change in acute promyelocytic leukaemia.

Rowley JD and 2 others. Lancet, 1977. Cited by 580 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Cite this record

ConductScience Library. 15/17 translocation, a consistent chromosomal change in acute promyelocytic leukaemia. Papers, record 65649. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/65649

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title: 15/17 translocation, a consistent chromosomal change in acute promyelocytic leukaemia.; PubMed
Journal: Lancet; PubMed
Year: 1977; PubMed
Publication types: Case Reports, Letter; PubMed
PubMed: https://pubmed.ncbi.nlm.nih.gov/65649/; PubMed
DOI: https://doi.org/10.1016/s0140-6736(77)91415-5; PubMed
The journal: https://conductscience.org/library/journal-index/2985213R; PubMed
Citations, by iCite: 580; iCite
Relative citation ratio, by iCite: 10.5; iCite
Revised in PubMed: 2019-06-10; PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Order	Author	Forename
1	Rowley JD	J D
2	Golomb HM	H M
3	Dougherty C	C

Source PubMed

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH term	Major
Chromosome Aberrations	Major topic
Chromosomes, Human, 13-15	Major topic
Chromosomes, Human, 16-18	Major topic
Leukemia, Myeloid, Acute	Major topic
Humans
Male

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

Trial	Title	The trial lists it as	Named in the paper's record
NCT06199557	A Study to Investigate Treatment of HU and VPA, or 6-MP and VPA in Unfit AML/HR-MDS Patients	Background

Source ClinicalTrials.gov

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References0

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

None in this release.

Cited by138

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 580 citations.

PMID	Title	Journal	Year	In Papers	Source
42,939,570	In Vitro Chromosome Translocations: Modeling Critical Drivers of Human Neoplasms.	Curr Issues Mol Biol	2026	https://conductscience.org/library/papers/42939570	PubMed
42,856,463	Tumor suppressor-like mutations mark a dosage-constrained dependency in leukemia.	bioRxiv	2026	https://conductscience.org/library/papers/42856463	PubMed
42,671,651	Cancer-associated fusion transcripts: mechanisms, functional roles, and clinical implications.	Clin Exp Med	2026	https://conductscience.org/library/papers/42671651	PubMed
41,975,751	Deep Learning Identifies Abnormal Promyelocytes in Peripheral Blood Based on Morphological Analysis.	Diagnostics (Basel)	2026	https://conductscience.org/library/papers/41975751	PubMed
40,496,324	Acute promyelocytic leukaemia in a Nigerian patient-a case report depicting challenges in the management of haematological malignancies in Nigeria.	Ecancermedicalscience	2025	https://conductscience.org/library/papers/40496324	PubMed
39,979,604	Distinct leukemogenic mechanism of acute promyelocytic leukemia based on genomic structure of PML::RARα.	Leukemia	2025	https://conductscience.org/library/papers/39979604	PubMed
39,874,494	ALLG APML5: bioavailability and safety of oral arsenic trioxide assessed during consolidation therapy for APL.	Blood Adv	2025	https://conductscience.org/library/papers/39874494	PubMed
39,017,850	Function of PML-RARA in Acute Promyelocytic Leukemia.	Adv Exp Med Biol	2024	https://conductscience.org/library/papers/39017850	PubMed
38,927,048	Advancements and Future Prospects in Molecular Targeted and siRNA Therapies for Chronic Myeloid Leukemia.	Biomolecules	2024	https://conductscience.org/library/papers/38927048	PubMed
38,611,029	History of Developing Acute Promyelocytic Leukemia Treatment and Role of Promyelocytic Leukemia Bodies.	Cancers (Basel)	2024	https://conductscience.org/library/papers/38611029	PubMed

1 to 10 of 138

See all 138 cited by

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed: 2026-11-06; PubMed
iCite: 2026-11-05; iCite
PMC's ID file: 2026-11-05; PMC's ID file
NIH RePORTER's grant and paper links: 2026-11-01; NIH RePORTER's grant and paper links
Trials: 2026-11-12
Gene search: 2026-11-11
Pipelines: 2026-09-18

Sources 11

ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
HGNCCC0
iCiteCC BY 4.0
NCBI GenePublic domain (US government)
NIH RePORTER's grant and paper linksPublic domain
Open TargetsCC0 1.0
PMC's ID filePublic domain (US government)
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0

Each source's terms

ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
HGNCCC0: https://www.genenames.org/about/license/
iCiteCC BY 4.0
NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/65649

GET https://conductscience.org/api/papers/v1/65649/cited_by?page=2

API reference For AI assistants